Home » Topics » Regulatory

Regulatory
RSS

Lyrica approved in E.U.

July 12, 2004

Eisai launches Apnission in Japan

July 6, 2004

Arava approved in Europe for active psoriatic arthritis

July 2, 2004

Change of indications for phase II trials of KOS-862

June 29, 2004

Biovail's NDA for novel dosage form of citalopram accepted for review

June 16, 2004

FDA approves Vidaza for treatment of MDS

May 24, 2004

FDA approves DepoDur for treatment of pain

May 21, 2004

New approval for Enbrel in psoriasis

May 5, 2004

New indication and strength approved for Hectorol

April 29, 2004

FDA approval for ChiRhoClin's human secretin

April 16, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM
BioWorld
Cytokinetics Inc. scored U.S. FDA marketing clearance Dec. 19 for Myqorzo (aficamten) 5-mg, 10-mg, 15-mg, and 20-mg tablets to improve functional capacity and...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....